Khiron Corporate Update: Company Reports Accelerated Increase in Medical Cannabis Prescriptions
TORONTO, Oct. 9, 2020 (Canada NewsWire via COMTEX) —
-- Khiron reaches more than 3,500 medical cannabis prescriptions filled -- Medical cannabis prescriptions increased by over 450% in Q3, compared to Q2 of 2020 -- Khiron's clinics exceeded 9,000 monthly patient consultations in September, marking a return to pre-pandemic monthly levels, supported by the launch of telehealth consultations -- Khiron was declared a National Strategic Project by the Government of Colombia in September, accelerating its ability to register and introduce new SKUs in the medical cannabis and consumer-packaged goods categories -- Khiron became the first company to sell medical cannabis in Peru, introducing its new CBD brand Alexin(TM), sold under its ...